Starting Oct. 1, Blue Cross Blue Shield Of Michigan And Blue Care Network Will Change The Prior Authorization Approval Criteria For Commercial PPO And HMO Plans For Weight Loss Drugs: Contrave, Generic Amphetamine Sulfate, Qsymia, Saxenda, Wegovy, Xenical
Starting Oct. 1, Blue Cross Blue Shield Of Michigan And Blue Care Network Will Change The Prior Authorization Approval Criteria For Commercial PPO And HMO Plans For Weight Loss Drugs: Contrave, Generic Amphetamine Sulfate, Qsymia, Saxenda, Wegovy, Xenical
從10月1日起，密歇根州藍十字藍盾和Blue Care Network將更改商業PPO和HMO減肥藥物計劃的事先授權批准標準：Contrave、仿製硫酸苯丙胺、Qsymia、Saxenda、Wegovy、Xenical
Starting Oct. 1, Blue Cross Blue Shield Of Michigan And Blue Care Network Will Change The Prior Authorization Approval Criteria For Commercial PPO And HMO Plans For Weight Loss Drugs: Contrave, Generic Amphetamine Sulfate, Qsymia, Saxenda, Wegovy, Xenical
從10月1日起，密歇根州藍十字藍盾和Blue Care Network將更改商業PPO和HMO減肥藥物計劃的事先授權批准標準：Contrave、仿製硫酸苯丙胺、Qsymia、Saxenda、Wegovy、Xenical
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。